FDA approves Lilly's Zepbound (tirzepatide) for chronic weight management
The FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that...
top of page
Browse by category
Search
STEP TEENS trial: Semaglutide in adolescents reduces weight and improves liver health
Two new secondary analyses of the STEP TEENS trial presented at this year's European Congress on Obesity have reported that almost half...
ECRI report identifies reasons weight loss drugs have been underutilised
ECRI, the largest non-profit patient safety organisation in the US, is calling on healthcare leaders to change their approach and fully...
Triptan migraine drugs may be effective in treating obesity
Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a study by scientists at UT Southwestern...
FDA approves Phase II trial for obesity-treating drug pemvidutide
The Food and Drug Administration (FDA) has approved a Phase II clinical trial for investigational obesity-treating drug pemvidutide. The...
AstraZeneca and Regeneron to develop obesity treatments
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed...
EBWMP plus anti-obesity medications results in greater weight loss
A Cleveland Clinic study has reported that adults with obesity lost significantly more weight when they had access to medications for...
FDA approves Novo Nordisk’s Wegovy (semaglutide 2.4 mg) for weight management
The FDA has approved Novo Nordisk’s Wegovy (the brand name for once-weekly semaglutide 2.4mg injection in the US) for chronic weight...
Browse by tag
bottom of page